The medical technology community has grown exponentially worldwide, with researchers, medical experts, and technology giants combining their forces – and their funding – to produce new medical solutions aimed at dramatically improving the lives of the global citizenry and pushing us further into the future as far as medical interventions and solutions are concerned.
A number of major medical technology companies in Singapore have recently started to accelerate their funding rounds, looking for new ways to improve their solutions, improve their research, and improve the breakthroughs that they are helping to pioneer.
Clearbridge Health is one of the most successful medical technology firms to become established in Singapore, and recently it has started to raise money through an Initial Public Offering.
So far raising $21.4 million through the first round of IPO funding, this company placed more than 88 million shares on the market at just $.28 apiece and are hoping to launch with a second round of funding before December 18, 2017.
During this first IPO, no shares are being made available to the general public, but the secondary market will no doubt be flooded with opportunities to buy into Clearbridge Health. This company has already started to expand its base of operations throughout Singapore and into Hong Kong, and they are responsible for some of the most exciting new medical technology coming out of Southeast Asia.
Specializing predominantly in the field of internal medicine, the leaders at Clearbridge Health are looking to pioneer new solutions designed at eradicating dangerous and deadly diseases while at the same time making surgery and other more invasive medical procedures a lot safer than they already are today.
Cancer and diabetes in particular are focused on in these facilities, and the research that they have been able to develop so far is helping firms around the world accelerate their own progress – benefiting the global medical community along the way.
Clearbridge Health is unique in that it offers a private-sector approach to cancer treatment and diabetes solutions, giving those that want to take advantage of private-sector breakthroughs the opportunity to do so on a parallel treatment track with plenty of “handholding” along the way. Clients of this medical technology firm are able to enjoy a more custom medical solution and more personal care, though a premium is charged at the same time.
$11 million of the initial funding round is already earmarked to be used to dramatically expand the medical clinic business that kept Clearbridge already operates. This company has already agreed to terms with the potential acquisition of a major medical center in the Philippines, which will dramatically improve their overall footprint in Southeast Asia while giving them new opportunities to research and pioneer game changing medical solutions.
$3 million more is expected to be invested into the group on a laboratory setting, and nearly $8 million has been set aside for capital to “keep the doors open”. This is a company that has already enjoyed a considerable amount of success in the medical technology field, and it’s one that is betting on itself – and one that outside investors are betting on as well – to continue to succeed going forward.
About the Author
Morris Edwards is a content writer at CompanyRegistrationinSingapore.com.sg, he writes different topics like Singapore tech start-up Sea targeting $1.35b in New York IPO, Launching a startup in Singapore? 4 things you need to know and all topics related to Tech and Business, if you are interested about Setting up a business in Singapore visit our website for more information.
Contact:
Company: Singapore Company Incorporation Consultants Pte Ltd
Address: 10 Anson Road International Plaza #27-15, Singapore 079903
Telephone: +65 66531211
E-mail: info@companyregistrationinsingapore.com.sg
Website: https://www.companyregistrationinsingapore.com.sg
